Meningococcal Vaccines Market
Report Highlights
Meningococcal Vaccines Market Size And Forecast
Meningococcal Vaccines Market was valued at USD 3.5 Billion in 2018 and is projected to reach USD 8.9 Billion by 2026, growing at a CAGR of 12.3% from 2019 to 2026.
Global Meningococcal Vaccines Market Outlook
The rising incidence of meningitis across the world has been majorly fueling the growth of the global meningococcal vaccines market. An increase in public-private partnerships to support the development of vaccines at low cost, and rising immunization programs and government initiatives are some other major factors expected to boost the market growth. The maintenance of cold chain for the delivery of vaccines leads to rise in cost of vaccination, is the restraining factor for the market growth. Furthermore, World Health Organization is promoting strategies for prevention of meningitis and is hoping to introduce this vaccine in a moderate or high rate of disease countries of African region, which are suffering from meningitis and they hope to achieve. This would create the growth opportunities in this market.
Global Meningococcal Vaccines Market Competitive Landscape
The Global Meningococcal Vaccines Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Biomed Pvt. Ltd., Neuron Biotech, Serum Institute of India Ltd., Baxter international, Novartis International, Pfizer Inc., JN-International Medical Corporation, GlaxoSmithKline plc., and Sanofi S.A.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.